Skip to main content

Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.

Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van Doorn J, Juul A

Publication: J Clin Lab Anal (1999) • Vol 13 • Page 166-72PMID: 10414596View on PubMedSuggested by: ISBER

Purpose

The purpose of this paper was to determine the effects of patient age and gender, anticoagulant, use of serum rather than plasma and freeze-thaw cycling on insulin-like growth factors (IGF) and IGF binding proteins (IGFBP) in blood.

Conclusion

IGF-I, IGF-II, IGFBP-3, IGFBP-6 and the acid-labile subunit of IGFBP (ALS) increased while IGFBP-2 decreased with age between birth and puberty in serum and/or plasma. After puberty, IGF-I, IGFBP-3, and ALS declined slowly with age while IGF-II, IGFBP-2, and IGFBP-6 remained relatively constant. Levels of IGF-I, IGFBP-3 and ALS were higher while IGFBP-2 and IGFBP-6 were generally lower in females than males in serum and/or plasma. IGF-I and II were 10% higher in serum than plasma, but the type of anticoagulant used had no effect on IGF-I or II levels in plasma. Serum had significantly higher IGFBP-3, IGFBP-6 and ALS levels and lower IGFBP-2 levels than EDTA-plasma. Serum had significantly higher IGFBP-2, IGFBP-6 and ALS levels than heparinated plasma, but there were no differences in IGFBP-3 levels between serum and heparinated plasma. IGFBP-3 and ALS levels were significantly higher and IGFBP-2 levels were significantly lower in heparinated plasma than in EDTA-plasma. IGF-I, IGF-II and IGFBP-3 levels, in plasma, were not significantly different after 5 freeze-thaw cycles.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient age and gender, anticoagulant, use of serum rather than plasma and freeze-thaw cycling on IGF and IGFBP in blood. Specimens used to measure IGF-I and ALS were kept frozen until use, but specimens used to measure IGF-II, IGFBP-2, IGFBP-3, and IGFBP-6 had been previously thawed.

Summary of Findings

IGF-I, IGF-II, IGFBP-3, IGFBP-6 and ALS levels increased while IGFBP-2 decreased with age between birth and puberty in serum and/or plasma. After puberty, IGF-I, IGFBP-3, and ALS declined slowly with age while IGF-II, IGFBP-2, and IGFBP-6 remained relatively constant. Levels of IGF-I and IGFBP-3 were 8% higher in females than males. Levels of ALS were generally higher, while IGFBP-2 and IGFBP-6 were generally lower in females than males in serum. There was no effect of gender on IGF-II levels. IGF-I and II were 10% higher in serum than in plasma (p<0.001), but the type of anticoagulant used had no effect on IGF-I or II levels in plasma. Serum had significantly higher IGFBP-3, IGFBP-6 and ALS levels and lower IGFBP-2 levels than EDTA-plasma. Serum had significantly higher IGFBP-2, IGFBP-6 and ALS levels than heparinated plasma, but there were no differences in IGFBP-3 levels between serum and heparinated plasma. IGFBP-3 and ALS levels were significantly higher (p<0.001 and p=0.009, respectively) while IGFBP-2 levels were significantly lower (p<0.001) in heparinated plasma than in EDTA-plasma. IGF-I, IGF-II and IGFBP-3 levels, in plasma, were not significantly different after 5 freeze-thaw cycles.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    ProteinImmunoassay
    ProteinImmunoradiometric assay
    ProteinELISA
    ProteinRadioimmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Minor ear infection
    Minor throat infection
    PreaquisitionPatient age
    5-65 years
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionAnticoagulant
    Citrate
    EDTA
    Heparin
    None
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    StorageFreeze/thaw cycling
    1 cycle
    2 cycles
    3 cycles
    4 cycles
    5 cycles